InvestorsHub Logo
icon url

Walshballs

12/04/13 2:21 PM

#22469 RE: BioChica #22468

Vascepa will live on amrn may not. Partner or buyout on the cheap coming to a theatre near you sometime after dec 20th
icon url

DeepBreath

12/04/13 3:41 PM

#22472 RE: BioChica #22468

Just so we are clear, I do not think amarin is going bankrupt anytime soon. I was quoting the author of the forbes article which states that if amarin cancelled the study, the cholesterol experts believed the NHLBI should pick up the study. I don't think Amarin will cancel the study, therefore if the NHLBI did pick up the study, Amarin would cease to exist. All Hypothetical based on the Forbes article.
icon url

DeepBreath

12/04/13 6:15 PM

#22478 RE: BioChica #22468

Biochica,

I am working on a letter and I believe it was you who mentioned the difference in label allowance between Lovaza and Vascepa. Can you provide me a synopsis on the difference or point me to articles that explain the difference?